BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32738929)

  • 1. SARS-CoV-2-related atypical thyroiditis.
    Muller I; Cannavaro D; Dazzi D; Covelli D; Mantovani G; Muscatello A; Ferrante E; Orsi E; Resi V; Longari V; Cuzzocrea M; Bandera A; Lazzaroni E; Dolci A; Ceriotti F; Re TE; Gori A; Arosio M; Salvi M
    Lancet Diabetes Endocrinol; 2020 Sep; 8(9):739-741. PubMed ID: 32738929
    [No Abstract]   [Full Text] [Related]  

  • 2. Cautious interpretation of antiphospholipid antibodies in COVID-19.
    Mehta S; Bhandari S; Mehta S
    Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19.
    Solodky ML; Galvez C; Russias B; Detourbet P; N'Guyen-Bonin V; Herr AL; Zrounba P; Blay JY
    Ann Oncol; 2020 Aug; 31(8):1087-1088. PubMed ID: 32360743
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19.
    Nie SF; Yu M; Xie T; Yang F; Wang HB; Wang ZH; Li M; Gao XL; Lv BJ; Wang SJ; Zhang XB; He SL; Qiu ZH; Liao YH; Zhou ZH; Cheng X
    Circulation; 2020 Aug; 142(6):608-610. PubMed ID: 32539541
    [No Abstract]   [Full Text] [Related]  

  • 5. Researchers Home in on COVID-19 Severity Biomarkers.
    Abbasi J
    JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
    Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
    Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy.
    Pasin L; Sella N; Correale C; Boscolo A; Rosi P; Saia M; Mantoan D; Navalesi P
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2341-2345. PubMed ID: 32425461
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-6 as a potential biomarker of COVID-19 progression.
    Ulhaq ZS; Soraya GV
    Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging key laboratory tests for patients with COVID-19.
    Kavsak PA; de Wit K; Worster A
    Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
    Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two consecutive myocardial tissue insults for inpatients with COVID-19.
    Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
    Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical laboratory and SARS-CoV-2 infection: where do we stand?
    Galli C; Plebani M
    Clin Chem Lab Med; 2020 Jun; 58(7):1139-1141. PubMed ID: 32242831
    [No Abstract]   [Full Text] [Related]  

  • 13. Preterm birth: Potential risk factor for greater COVID-19 severity?
    Debevec T; Burtscher J; Millet GP
    Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
    [No Abstract]   [Full Text] [Related]  

  • 14. Mild versus severe COVID-19: Laboratory markers.
    Velavan TP; Meyer CG
    Int J Infect Dis; 2020 Jun; 95():304-307. PubMed ID: 32344011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
    Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
    Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
    Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
    Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan.
    Lu X; Xu S
    Crit Care; 2020 May; 24(1):199. PubMed ID: 32375850
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.
    Xiong M; Liang X; Wei YD
    Br J Haematol; 2020 Jun; 189(6):1050-1052. PubMed ID: 32304581
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
    Masi P; Hékimian G; Lejeune M; Chommeloux J; Desnos C; Pineton De Chambrun M; Martin-Toutain I; Nieszkowska A; Lebreton G; Bréchot N; Schmidt M; Edouard Luyt C; Combes A; Frere C
    Circulation; 2020 Aug; 142(6):611-614. PubMed ID: 32776849
    [No Abstract]   [Full Text] [Related]  

  • 20. Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects.
    Mojoli F; Mongodi S; Grugnetti G; Muzzi A; Baldanti F; Bruno R; Triarico A; Iotti GA
    Anesthesiology; 2020 Jul; 133(1):244-246. PubMed ID: 32235155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.